Strategic Capital Advisers, Inc. Abbott Laboratories Transaction History
Strategic Capital Advisers, Inc.
- $121 Million
- Q2 2022
A detailed history of Strategic Capital Advisers, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Capital Advisers, Inc. holds 1,956 shares of ABT stock, worth $222,279. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,956
Previous 1,862
5.05%
Holding current value
$222,279
Previous $220,000
3.64%
% of portfolio
0.18%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,136Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.45 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.16 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.5 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...